Today at #AACR26, Cole Peters will present research on a promising new combination therapy for an aggressive pediatric cancer that pairs an engineered oncolytic virus with immunotherapy, reducing tumor growth and improving survival in preclinical models.
https://
bit.ly/3QFbsE6